201 related articles for article (PubMed ID: 22668803)
1. Management of macrolide-resistant Mycoplasma pneumoniae infection.
Saegeman V; Proesmans M; Dumke R
Pediatr Infect Dis J; 2012 Nov; 31(11):1210-1. PubMed ID: 22668803
[No Abstract] [Full Text] [Related]
2. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
Dumke R; Stolz S; Jacobs E; Juretzek T
Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
[TBL] [Abstract][Full Text] [Related]
4. [Macrolide resistance in Mycoplasma pneumoniae by recurrence and extended illness].
Uldum SA; Amberg P; Jensen JS
Ugeskr Laeger; 2012 Mar; 174(11):730-1. PubMed ID: 22409896
[TBL] [Abstract][Full Text] [Related]
5. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
6. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
[TBL] [Abstract][Full Text] [Related]
7. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
8. [Macrolide-resistant Mycoplasma pneumoniae].
Morozumi M; Ubukata K
Nihon Rinsho; 2012 Feb; 70(2):251-5. PubMed ID: 22413527
[TBL] [Abstract][Full Text] [Related]
9. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
[TBL] [Abstract][Full Text] [Related]
10. [Continuous versus intermittent azithromycin administration for treatment of Mycoplasma pneumonia-induced pneumonia: effects and drug resistance in rats].
Wei W
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1918-9, 1922. PubMed ID: 20813702
[TBL] [Abstract][Full Text] [Related]
11. Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience.
Lu YJ; Chen TH; Lin LH; Shen CM; Huang CH
J Microbiol Immunol Infect; 2008 Aug; 41(4):307-10. PubMed ID: 18787737
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains.
Okazaki N; Ohya H; Sasaki T
Jpn J Infect Dis; 2007 Sep; 60(5):325-6. PubMed ID: 17881881
[No Abstract] [Full Text] [Related]
14. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
[TBL] [Abstract][Full Text] [Related]
15. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
16. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.
Cardinale F; Chironna M; Dumke R; Binetti A; Daleno C; Sallustio A; Valzano A; Esposito S
Eur Respir J; 2011 Jun; 37(6):1522-4. PubMed ID: 21632830
[No Abstract] [Full Text] [Related]
17. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States.
Yamada M; Buller R; Bledsoe S; Storch GA
Pediatr Infect Dis J; 2012 Apr; 31(4):409-0. PubMed ID: 22209916
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
[TBL] [Abstract][Full Text] [Related]
19. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.
Chironna M; Sallustio A; Esposito S; Perulli M; Chinellato I; Di Bari C; Quarto M; Cardinale F
J Antimicrob Chemother; 2011 Apr; 66(4):734-7. PubMed ID: 21393214
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.
Hsieh YC; Tsao KC; Huang CG; Tong S; Winchell JM; Huang YC; Shia SH; Lai SH; Lin TY
Pediatr Infect Dis J; 2012 Feb; 31(2):208-9. PubMed ID: 21941216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
